April 01, 2021
Article
April is Parkinson’s Awareness Month, so what better time to refresh your understanding and promote awareness around Parkinson disease than now?
March 19, 2021
Nine in 10 patients with multiple sclerosis who received the medication did not have worsening of 3-month disability, and ponesimod showed a numerical benefit in delaying disability progression.
March 18, 2021
Additionally, the study revealed for the first time the physiological reason for the neutral protection is increased blood flow to the brain as a result of higher levels of progesterone.
February 23, 2021
The study compared step impairments across the cognitive spectrum, including people with subjective cognitive impairment, Parkinson disease, mild cognitive impairment, Alzheimer disease, Lewy body dementia, and frontotemporal dementia, as well as cognitively healthy controls.
February 12, 2021
The investigators also found significant racial disparities, with Black patients with dementia more likely to be infected with COVID-19 than white patients with dementia.
February 10, 2021
Some OTC nonsteroidal anti-inflammatory drugs or combination analgesics can be used to treat migraine in children.
Patients with multiple sclerosis who rely on family members as caregivers may be at particular risk for mistreatment, as those caregivers struggle to balance work, childcare, and health concerns of their own.
The product portfolio includes lamotrigine (ET-105), zonisamide (ET-104), and topiramate (ET-101). These medications are currently under review with the FDA.
February 09, 2021
Migraine attacks are the leading cause of disability in individuals younger than 50 years and predominantly affect women.
February 05, 2021
The diagnosis and management of neurologic conditions can be more complex when patients are at the extremes of age.
